Arax Advisory Partners’s Inspire Medical Systems INSP Stock Holding History

Arax Advisory Partners’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$80.9K	Buy	+1,814	New	+$86K	﹤0.01%	2884
2026 Q1	–	Sell	-181	Closed	-$16.7K	–	4066
2025 Q4	$16.7K	Buy	+181	New	+$17.3K	﹤0.01%	2212
2025 Q3	–	Sell	-6	Closed	-$779	–	3949
2025 Q2	$779	Buy	+6	New	+$870	﹤0.01%	2857
2025 Q1	–	Sell	-37	Closed	-$6.86K	–	2867
2024 Q4	$6.86K	Hold	37	–	–	﹤0.01%	1628
2024 Q3	$7.81K	Hold	37	–	–	﹤0.01%	1514
2024 Q2	$4.95K	Buy	+37	New	+$7K	﹤0.01%	1601

Other funds holding INSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Arax Advisory Partners's INSP Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Inspire Medical Systems (INSP) in Q2 2026: 1,814 shares worth $80.9K. The stake represents ﹤0.01% of the portfolio and ranks #2884 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in INSP as recently as Q4 2025.

Arax Advisory Partners first reported a position in INSP in Q2 2024 and has held it in 6 quarters since. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

Arax Advisory Partners held 1,814 shares of Inspire Medical Systems worth $80.9K as of Q2 2026.
Inspire Medical Systems was a new Arax Advisory Partners position in Q2 2026.
Inspire Medical Systems made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2884 holding.
Arax Advisory Partners first reported a position in Inspire Medical Systems in Q2 2024 and has held it in 6 quarters since.
275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.